Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study (Q79805150)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2006

Language	Label	Description	Also known as
English	Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study	scientific article published on 01 August 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Langerhans cell histiocytosis specific to childhood

1 reference

based on heuristic

inferred from title

author name string

Akira Morimoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Satoshi Ikushima

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Naoko Kinugawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Eiichi Ishii

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Urara Kohdera

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masahiro Sako

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Junichiro Fujimoto

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fumio Bessho

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Keizo Horibe

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yukiko Tsunematsu

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shinsaku Imashuku

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Japan Langerhans Cell Histiocytosis Study Group

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 August 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

107

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

613-619

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Langerhans-cell histiocytosis 'insight into DC biology'.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Histiocytosis X--comparison of three treatment regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathology of CNS disease in Langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Histiocytosis X—an analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21985

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804933%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79805150&oldid=2125100677"